1. Home
  2. NYAX vs DVAX Comparison

NYAX vs DVAX Comparison

Compare NYAX & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$55.34

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.48

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
DVAX
Founded
2005
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
NYAX
DVAX
Price
$55.34
$15.48
Analyst Decision
Buy
Hold
Analyst Count
5
5
Target Price
$47.50
$26.50
AVG Volume (30 Days)
9.0K
2.9M
Earning Date
03-03-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$369,938,000.00
$330,514,000.00
Revenue This Year
$29.95
$24.63
Revenue Next Year
$23.27
$15.85
P/E Ratio
$84.78
N/A
Revenue Growth
26.84
26.73
52 Week Low
$32.38
$9.20
52 Week High
$60.77
$15.73

Technical Indicators

Market Signals
Indicator
NYAX
DVAX
Relative Strength Index (RSI) 53.94 75.83
Support Level $53.79 $15.46
Resistance Level $59.84 $15.73
Average True Range (ATR) 1.03 0.06
MACD -0.77 -0.17
Stochastic Oscillator 34.98 6.52

Price Performance

Historical Comparison
NYAX
DVAX

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: